Researchers Find Vulnerability in Metabolism That Drives Lung Cancer Growth
Researchers from Mass General Brigham worked with a team to identify an enzyme that boosts cancer cell metabolism to fuel growth in a subset of lung cancers.
Staff StoryJun | 16 | 2020
One of the many departments that has witnessed firsthand the extraordinary work of staff within Nursing & Patient Care Services is Massachusetts General Hospital's Police, Security and Outside Services.
As national Nurses Week approached in early May, Bonnie Michelman, executive director of Police and Security, was looking for a way for her department to pay tribute to the nursing staff, and she enlisted the help of security officer Jay Mulligan, who also happens to be a talented artist.
The result: An acrylic-on-canvas depiction of Police and Security’s admiration. “Bonnie and I collaborated on the many elements we wanted to include in the painting,” says Mulligan. Using a number of reference photographs, he’d work on the painting by day before heading to Mass General to work the night shift.
“In my 20 years at Mass General, I’ve seen the extraordinary job that nurses usually do, but over the past few months, they reached a new level,” says Mulligan. “We just wanted to show that we support them.”
The painting will be hung this week in the Lunder display case in the main lobby.
Researchers from Mass General Brigham worked with a team to identify an enzyme that boosts cancer cell metabolism to fuel growth in a subset of lung cancers.
Given uncertainties about future PEPFAR funding, researchers modeled the impact of abrupt PEPFAR cutbacks in South Africa
Thurman M. Wheeler, MD, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in Nature Communications, “Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1.”
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital is thrilled to announce the launch of our newest initiative, ALS MyMatch, an innovative, early phase, biomarker-driven clinical trial network program.
From the Bench- The Labs of Drs. Andrew Stern and Clare Baecher-Allen
Steven Chen, MD, MPH discusses important signs of skin cancer to watch for and shares skin cancer prevention tips you need to stay safe in all four seasons.
Researchers from Mass General Brigham worked with a team to identify an enzyme that boosts cancer cell metabolism to fuel growth in a subset of lung cancers.
Given uncertainties about future PEPFAR funding, researchers modeled the impact of abrupt PEPFAR cutbacks in South Africa
Thurman M. Wheeler, MD, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in Nature Communications, “Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1.”
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital is thrilled to announce the launch of our newest initiative, ALS MyMatch, an innovative, early phase, biomarker-driven clinical trial network program.